Author Correction: Pharmacokinetics, mass balance, and metabolism of [¹⁴C]vicagrel, a novel irreversible P2Y₁₂ inhibitor in humans

Affiliations

• ¹ State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China.
• ² University of Chinese Academy of Sciences, Beijing 100049, China.
• ³ Department of Clinical Pharmacology, the First Affiliated Hospital of Soochow University, Suzhou, 215123, China.
• ⁴ Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou, 215006, China.
• ⁵ Jiangsu Vcare PharmaTech Co. Ltd., Nanjing, 211800, China.
• ⁶ State Key Laboratory of Natural Medicines and Center of Drug Discovery, College of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China.
• ⁷ Guangzhou JOYO Pharma Ltd., Shanghai, 201203, China.
• ⁸ State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China. [email protected].
• ⁹ University of Chinese Academy of Sciences, Beijing 100049, China. [email protected].
• ¹⁰ Department of Clinical Pharmacology, the First Affiliated Hospital of Soochow University, Suzhou, 215123, China. [email protected].
• ¹¹ Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou, 215006, China. [email protected].
• ¹² State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201210, China. [email protected].
• ¹³ University of Chinese Academy of Sciences, Beijing 100049, China. [email protected].